Drug Use Investigation of Zevalin.
Phase of Trial: Phase IV
Latest Information Update: 04 Jan 2018
At a glance
- Drugs Ibritumomab tiuxetan (Primary)
- Indications B cell lymphoma; Mantle-cell lymphoma; Non-Hodgkin's lymphoma
- Focus Adverse reactions
- Acronyms ZEVALIN-DUI
- Sponsors Bayer; Spectrum Pharmaceuticals
- 09 Nov 2011 Additional trial acronym ZEVALIN-DUI identified as reported by ClinicalTrials.gov.
- 10 Oct 2011 New trial record